N4 Pharma plc (N4P) ORD GBP0.004
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.38p
0.40p
0.80p
£3.12 million
0.38p
0.37p
0.35p
n/a
0.00p (0.00%) Previous:
0.00p
142,750
n/a
300,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue (£m) | 0.01 | n/a |
| Profit before tax (£m) | (1.22) | (1.42) |
| Adjusted EPS (p): | (0.31) | (0.52) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
N4 Pharma reports narrower full-year operating loss
6 June 2025 12:14
-
N4 Pharma files for new UK patent
4 December 2024 14:46
-
N4 Pharma reports positive progress with SRI collaboration
20 August 2024 10:10
-
Directorate Change
8 July 2025 07:00
-
Result of AGM
30 June 2025 14:15
-
AGM Statement
30 June 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.